RankAlpha logo
Back to Rankings

SNY

SanofiC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
SNY vs peer average
52/100
SNY vs. peer average (C vs. C)
Grade spread
A 1 · B 1 · C 5 · D 2 · F 1
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

AZN is the first available peer comparator.

AstraZeneca — strong oncology/immunology footprint and similar mid-term revenue drivers.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerAZNAstraZeneca
SNY
Sanofi
AZN
AstraZeneca
Grade
C
F
Momentum
36
35
Value
60
62
Sentiment
70
5
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Mixed
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs AZN

SNY / AZN
Grade Position
In line
SNY vs. peer average (C vs. C)
52/100
Momentum
36
SNY
Value
60
AZN
Sentiment
70
SNY

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs SNY
1
AZN
AZN
F
20/100
+2
2
GSK
GSK
D
40/100
+1
3
NVS
NVS
C
60/100
Even
4
VRTX
Vertex Pharmaceuticals Inc Common
B
80/100
-1
5
BMY
Bristol-Myers Squibb Co Common
C
60/100
Even
AZN is the first peer returned for this comparison set.